Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01189 (beta-endorphin)
 21,003 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The present study was aimed to examine possible influences of bradykinin (BK) and substance P (SP) on met-enkephalin (ME)-like peptide content in the rat incisor pulp. Des-Arg9-[Leu8]-BK, a potent BK-antagonist, significantly reduced the increased content of ME-like peptides induced by noxious stimulation, while the effect of BK-antagonist was reversed in combination with BK. Morphine decreased the increased content of ME-like peptides. Ethylketocyclazocine, a kappa-agonist, also decreased the increased content of the peptides. From these results, it was suggested that BK might be a trigger in the increase of ME-like peptide content induced by noxious stimulation and, in contrast, ME-like peptides in the pulp might inhibit BK release from the pulp in a negative feedback mechanism. On the other hand, [D-Pro2,D-Trp7,9]-SP, a potent SP-antagonist, did not show any significant influence to ME-like peptide content in the pulp. Furthermore, the content was not changed following cutting of inferior alveolar nerve. From these results, it was suggested that ME-like peptides in the pulp cells might be independent on SP-containing nerves in the pulp.
 ...
PMID:Influences of bradykinin and substance P on the met-enkephalin-like peptide content in the rat incisor pulp. 242 25

In this study we examined the interaction of opiates with kappa binding sites in the bovine adrenal medulla. [3H]Ethylketocyclazocine (EKC), [3H]etorphine, and [3H]bremazocine stereoselective bindings were used to assay these interactions. The kappa sites were found to be heterogeneous: [3H]bremazocine identified with high affinity all subtypes of these sites. [3H]EKC, in the presence of saturating concentrations of [D-Ala2, D-Leu5]-enkephalin (DADLE) (5 microM), was used to identify kappa 1 sites, on which dynorphin A (1-13) bound with high affinity. Either [3H]EKC or [3H]etorphine in the presence of 5 microM DADLE identified the kappa 2 subtype. This subtype was found to interact with beta-endorphin and especially with the octapeptide Met5-enkephalyl-Arg6-Gly7-Leu8. Furthermore, [3H]etorphine identified in the bovine adrenal medulla a third high-affinity component, in the presence of 5 microM DADLE. This residual interaction was found to be equally stereoselective and presenting kappa selectivity. Met5-enkephalyl-Arg6-Phe7 interacted preferentially with this site. The three kappa subtypes interacted differentially with monovalent (Na+, K+, and Li+) and divalent (Ca2+, Mg2+, and Mn2+) ions by modification of the apparent concentration of the accessible sites and/or by changes of the apparent KD for radioligands. Modifying agents (proteolytic enzymes, thiol-modifying reagents, and A2-phospholipase) produced different effects on each subtype of the kappa site, suggesting a different protein (or protein-lipid?) composition.
 ...
PMID:Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. 299 10

Methionine enkephalin, leucine enkephalin, [D-Ala2, D-Leu5] enkephalin, alpha-neoendorphin, beta-endorphin, dynorphin (1-13) and ethylketocyclazocine inhibited the contractions of rabbit ear artery ring segments elicited by transmural nerve stimulation at 8 Hz. Ethylketocyclazocine, dynorphin (1-13) and leucine enkephalin produced partial inhibition, their apparent intrinsic activities (alpha) being 0.57, 0.75 and 0.66, respectively. Morphine and normorphine, which are agonists at mu-receptors, did not inhibit the response of the artery. Naloxone antagonized the actions of opioids and ethylketocyclazocine, and was more effective against methionine enkephalin, leucine enkephalin and [D-Ala2, D-Leu5] enkephalin than against alpha-neoendorphin, ethylketocyclazocine and dynorphin (1-13). The pA2 values of naloxone against so-called delta-agonists were approx. 8.5, and against so-called kappa-agonists were approx. 7.7. The supposed kappa-antagonist, Mr2266, was more effective than naloxone in antagonizing the actions of alpha-neoendorphin, and the kappa-agonists dynorphin (1-13) and ethylketocyclazocine. The pA2 values of Mr2266 against kappa-agonists were 8.5-9.0, and against delta-agonists were 7.8 or less. The opioid peptides and opioids tested did not cause dilatation of the artery previously contracted with histamine. These results suggest that the opioid peptides and ethylketocyclazocine acted on opioid receptors at adrenergic nerve terminals in the ear artery. The opioid receptors appear to be of the delta- and kappa-types, not the mu-type.
 ...
PMID:Opioid receptor types on adrenergic nerve terminals of rabbit ear artery. 299 21

Rat erythrocyte ghosts containing 45Ca++, EGTA, ATP and Pipes buffer (pH 7.2) were prepared for studying opioid effects on Ca++ flux. Ethylketocyclazocine and dynorphin 1-13 (dynorphin) dose-dependently inhibited La+++-sensitive outward 45Ca++ movement at nM concentrations and the effect was naloxone reversible. Morphine and beta-endorphin were also effective at higher concentrations, whereas levorphanol and leu-enkephalin were ineffective. None of the opioids studied inhibited 45Ca++ inward movement. Based on these findings, it is concluded that rat erythrocyte possesses k-type opioid receptors through which the Ca++-pump may be inhibited.
 ...
PMID:Possible inhibition of Ca++ pump of rat erythrocyte ghosts by opioid k agonists. 631 22

[3H]Ethylketocyclazocine, in the presence of mu, delta and kappa-1 blocking agents, labels a high-affinity, saturable binding site in rat brain which we previously concluded might be the beta-endorphin-selective epsilon opioid receptor. However, studies failing to establish clearly the existence of the site in species other than rat raised the possibility that it might be an artifact or a unique constituent of rat tissues. Neither appears to be the case. We report here that, like other types of receptors, the site is proteinaceous with a sulfhydryl group within the binding site itself. Furthermore, the site appears to exist in two interchangeable, GTP-gamma-S-sensitive states which are readily distinguished by beta-endorphin, but not (-)-[3H]ethylketocyclazocine, and which are likely to be the site coupled to and uncoupled from a G protein. The putative epsilon receptor is not a peculiarity of rat brain but is readily measurable in forebrain of guinea pig, cow, chicken and pig brain as well. In fact, in all of the species examined, it is more abundant than mu, delta or kappa-1 receptors, representing 38 to 55% of the total opioid receptor population. The binding selectivity profile for drugs and the structure-activity relationship for beta-endorphin analogs indicated that the pharmacological properties of the putative epsilon receptor in brain are remarkably correlated with those of the epsilon receptor that was first hypothesized to exist in rat vas deferens and of the epsilon receptor that has been hypothesized to mediate the supraspinal analgesic effects of beta-endorphin.
 ...
PMID:Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. 838 Aug 65